Structures by: Fun H. K.
Total: 1 720
2-(Biphenyl-4-yl)-5-[3-(4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine- 5-ylsulfonyl)thiophen-2-yl]-1,3,4-oxadiazole
C25H19N3O3S3
Acta Crystallographica Section E (2011) 67, 10 o2781-o2782
a=7.91080(10)Å b=12.09430(10)Å c=12.9498(2)Å
α=69.2530(10)° β=76.7940(10)° γ=77.4600(10)°
3-Benzyl-2-(furan-2-yl)-1,3-thiazolidin-4-one
C14H13NO2S
Acta Crystallographica Section E (2011) 67, 10 o2807-o2808
a=13.2901(2)Å b=9.63600(10)Å c=9.91520(10)Å
α=90.00° β=102.8550(10)° γ=90.00°
(2,4-Dihydroxy-6-methoxyphenyl)(3,5-dihydroxyphenyl)methanone monohydrate
C14H12O6,H2O
Acta Crystallographica Section E (2011) 67, 10 o2717-o2718
a=7.70870(10)Å b=8.40500(10)Å c=11.23800(10)Å
α=82.4010(10)° β=75.5700(10)° γ=67.8420(10)°
<i>N</i>'-(2,6-Difluorobenzylidene)pyridine-4-carbohydrazide
C13H9F2N3O
Acta Crystallographica Section E (2012) 68, 5 o1484
a=6.84620(10)Å b=24.7903(5)Å c=8.37190(10)Å
α=90.00° β=125.2490(10)° γ=90.00°
<i>N</i>-(2,4-Dimethylphenyl)-2,2-diphenylacetamide
C22H21NO
Acta Crystallographica Section E (2012) 68, 5 o1316-o1317
a=9.5520(9)Å b=10.2011(10)Å c=17.9656(17)Å
α=91.030(2)° β=98.957(2)° γ=90.377(2)°
(1<i>Z</i>,2<i>E</i>)-<i>N</i>'-{1-[2-(4-Bromophenyl)hydrazin-1-ylidene]-1-chloropropan-2-ylidene}thiophene-2-carbohydrazide
C14H12BrClN4OS
Acta Crystallographica Section E (2012) 68, 5 o1510-o1511
a=13.5502(14)Å b=3.8932(4)Å c=29.816(3)Å
α=90.00° β=103.075(2)° γ=90.00°
<i>N</i>-[(4-Methylphenyl)sulfonyl]acetamide
C9H11NO3S
Acta Crystallographica Section E (2012) 68, 7 o2025
a=9.2514(6)Å b=5.1900(3)Å c=20.5873(13)Å
α=90.00° β=95.070(2)° γ=90.00°
3-(1-Benzofuran-2-yl)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione monohydrate
C10H7N3OS,H2O
Acta Crystallographica Section E (2012) 68, 7 o2067
a=7.14460(10)Å b=8.80750(10)Å c=17.3274(2)Å
α=90.00° β=111.9420(10)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-4-Bromobenzylidene]-1-benzofuran-2-carbohydrazide monohydrate
C16H11BrN2O2,H2O
Acta Crystallographica Section E (2012) 68, 7 o2121
a=25.0594(4)Å b=4.67180(10)Å c=12.6166(2)Å
α=90.00° β=99.1750(10)° γ=90.00°
(<i>E</i>)-4-Hydroxy-<i>N</i>'-(2-hydroxy-4-methoxybenzylidene)benzohydrazide
C15H14N2O4
Acta Crystallographica Section E (2012) 68, 7 o2279
a=15.1982(2)Å b=8.24160(10)Å c=10.79000(10)Å
α=90.00° β=101.1730(10)° γ=90.00°
2-{2-[(<i>E</i>)-(2-Benzoylhydrazin-1-ylidene)methyl]phenoxy}acetic acid
C16H14N2O4
Acta Crystallographica Section E (2012) 68, 7 o2260-o2261
a=12.2173(7)Å b=7.8523(5)Å c=15.6025(9)Å
α=90.00° β=108.5770(10)° γ=90.00°
1-Chloro-1-[(<i>Z</i>)-2-phenylhydrazin-1-ylidene]propan-2-one
C9H9ClN2O
Acta Crystallographica Section E (2012) 68, 7 o2263
a=7.2681(14)Å b=12.361(2)Å c=10.704(2)Å
α=90.00° β=101.158(3)° γ=90.00°
2-[(1<i>H</i>-Benzimidazol-2-yl)sulfanyl]-1-phenylethanone
C15H12N2OS
Acta Crystallographica Section E (2012) 68, 7 o2262
a=14.7849(13)Å b=9.2643(8)Å c=9.7859(8)Å
α=90.00° β=106.7920(10)° γ=90.00°
(<i>Z</i>)-3-(4-Chlorophenyl)-2-(2-phenylcyclohex-2-en-1- ylimino)thiazolidin-4-one
C21H19ClN2OS
Acta Crystallographica Section E (2012) 68, 7 o1999-o2000
a=9.1139(3)Å b=17.4562(6)Å c=12.9246(4)Å
α=90.00° β=118.640(2)° γ=90.00°
(<i>Z</i>)-3-(4-Bromophenyl)-2-[(2-phenylcyclohex-2-en-1-yl)imino]-1,3- thiazolidin-4-one
C21H19BrN2OS
Acta Crystallographica Section E (2012) 68, 7 o1994
a=9.45730(10)Å b=16.6662(3)Å c=13.8812(2)Å
α=90.00° β=122.6650(10)° γ=90.00°
Ethyl 2-amino-4,5-dimethylthiophene-3-carboxylate
C9H13NO2S
Acta Crystallographica Section E (2012) 68, 7 o2111
a=7.9487(2)Å b=9.8939(3)Å c=13.4348(4)Å
α=90.00° β=106.143(2)° γ=90.00°
(2<i>E</i>)-2-[(3-Methyl-5-phenoxy-1-phenyl-1<i>H</i>-pyrazol-4- yl)methylidene]hydrazinecarbothioamide
C18H17N5OS
Acta Crystallographica Section E (2012) 68, 7 o2146-o2147
a=8.82800(10)Å b=10.8519(2)Å c=17.7353(2)Å
α=90.00° β=94.3790(10)° γ=90.00°
Bromido({2-[2-(diphenylphosphanyl)benzylidene]hydrazin-1-ylidene}(4- methoxyanilino)methanethiolato)palladium(II) acetone monosolvate
C27H23BrN3OPPdS,C3H6O
Acta Crystallographica Section E (2012) 68, 7 m991-m992
a=9.75940(10)Å b=13.7946(2)Å c=21.8681(3)Å
α=90.00° β=104.0920(10)° γ=90.00°
3,3'-Diethyl-1,1'-(1,4-phenylenedimethylene)diimidazol-3-ium bis(hexafluorophosphate)
C18H24N42,2(F6P)
Acta Crystallographica Section E (2012) 68, 7 o2280
a=8.5441(5)Å b=8.6018(5)Å c=9.5626(6)Å
α=67.9130(10)° β=77.9280(10)° γ=67.8370(10)°
(<i>E</i>)-4-Methoxy-<i>N</i>'-(2,4,5-trimethoxybenzylidene)benzohydrazide hemihydrate
C18H20N2O5,0.5(H2O)
Acta Crystallographica Section E (2014) 70, 2 o150-o151
a=13.4405(3)Å b=16.9172(3)Å c=7.6841(2)Å
α=90.00° β=96.0840(10)° γ=90.00°
1-(2,4-Dinitrophenyl)-2-[(<i>E</i>)-(3,4,5-trimethoxybenzylidene)]hydrazine
C16H16N4O7
Acta Crystallographica Section E (2014) 70, 2 o188-o189
a=7.4724(4)Å b=14.3106(7)Å c=16.1549(7)Å
α=90.00° β=90.00° γ=90.00°
5-Propyl-6-(<i>p</i>-tolylsulfanyl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C14H16N2O2S
Acta Crystallographica Section E (2014) 70, 2 o179-o180
a=11.8356(3)Å b=10.3040(2)Å c=13.3999(3)Å
α=90.00° β=119.850(2)° γ=90.00°
2-[(<i>E</i>)-2-(4-Ethoxyphenyl)ethenyl]-1-methylquinolinium 4-fluorobenzenesulfonate
C20H20NO,C6H4FO3S
Acta Crystallographica Section E (2014) 70, 1 o11-o12
a=6.4366(3)Å b=9.8909(5)Å c=34.3628(15)Å
α=90.00° β=95.102(2)° γ=90.00°
(2<i>E</i>)-1-(4,4''-Difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)-3-(2- fluorophenyl)prop-2-en-1-one
C28H19F3O2
Acta Crystallographica Section E (2012) 68, 7 o2024
a=13.75920(10)Å b=6.78980(10)Å c=22.4361(3)Å
α=90.00° β=101.9080(10)° γ=90.00°
(<i>E</i>)-1-(2,4-Dinitrophenyl)-2-[1-(3-methoxyphenyl)ethylidene]hydrazine
C15H14N4O5
Acta Crystallographica Section E (2012) 68, 7 o2144-o2145
a=7.5612(13)Å b=10.4517(18)Å c=19.516(3)Å
α=76.034(4)° β=89.531(4)° γ=84.052(4)°
<i>N</i>'-[(<i>E</i>)-3-Chloro-2-fluorobenzylidene]-6- methylnicotinohydrazide monohydrate
C14H11ClFN3O,H2O
Acta Crystallographica Section E (2012) 68, 7 o2122
a=9.7898(12)Å b=6.4440(8)Å c=23.121(3)Å
α=90.00° β=106.614(5)° γ=90.00°
(<i>E</i>)-<i>N</i>'-(4-Chlorobenzylidene)-1-benzofuran-2-carbohydrazide monohydrate
C16H11ClN2O2,H2O
Acta Crystallographica Section E (2012) 68, 7 o2163
a=24.6121(15)Å b=4.6625(3)Å c=12.6570(8)Å
α=90.00° β=99.2940(10)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-4-Chlorobenzylidene]pyridine-4-carbohydrazide monohydrate
C13H10ClN3O,H2O
Acta Crystallographica Section E (2012) 68, 7 o2303-o2304
a=14.1645(7)Å b=14.6276(7)Å c=14.0817(7)Å
α=90.00° β=119.220(2)° γ=90.00°
3-Methyl-4-[2-(4-nitrophenyl)hydrazin-1-ylidene]-5-oxo-4,5-dihydro-1<i>H</i>- pyrazole-1-carbothioamide
C11H10N6O3S
Acta Crystallographica Section E (2012) 68, 7 o2162
a=11.5331(4)Å b=17.2540(6)Å c=13.6025(5)Å
α=90.00° β=105.840(2)° γ=90.00°
<i>N</i>'-[1-(4-Chlorophenyl)ethylidene]-5-methyl-1-(4-nitrophenyl)-1<i>H</i>- 1,2,3-triazole-4-carbohydrazide
C18H15ClN6O3
Acta Crystallographica Section E (2012) 68, 7 o2164
a=8.66030(10)Å b=10.28440(10)Å c=10.40330(10)Å
α=83.8160(10)° β=81.4020(10)° γ=76.3730(10)°
4-Bromoacetyl-3-phenylsydnone
C10H7BrN2O3
Acta Crystallographica Section E (2012) 68, 7 o2103
a=7.2030(2)Å b=5.87780(10)Å c=25.1133(5)Å
α=90.00° β=91.104(2)° γ=90.00°
3,3'-Di-<i>n</i>-propyl-1,1'-(1,3-phenylenedimethylene)di(1<i>H</i>- imidazol-3-ium) bis(hexafluorophosphate)
C20H28N42,2(F6P)
Acta Crystallographica Section E (2012) 68, 7 o2153
a=7.2623(2)Å b=11.3926(3)Å c=15.9191(4)Å
α=86.1570(10)° β=80.917(2)° γ=88.946(2)°
6-Methoxy-4-(2,4,5-trimethoxyphenyl)-2,2'-bipyridine-5-carbonitrile
C21H19N3O4
Acta Crystallographica Section E (2013) 69, 10 o1500-o1501
a=14.9967(3)Å b=7.4039(2)Å c=17.5795(4)Å
α=90.00° β=114.0800(10)° γ=90.00°
(<i>E</i>)-2-[4-(Diethylamino)styryl]-1-methylquinolinium 4-fluorobenzenesulfonate monohydrate
C22H25N2,C6H4FO3S,H2O
Acta Crystallographica Section E (2013) 69, 10 o1510-o1511
a=13.366(2)Å b=10.2326(17)Å c=19.891(3)Å
α=90.00° β=113.004(8)° γ=90.00°
Poly[μ~5~-(4-methoxybenzenesulfonato)-sodium]
C7H7NaO4S
Acta Crystallographica Section E (2013) 69, 10 m558
a=8.3121(8)Å b=6.0287(6)Å c=35.930(3)Å
α=90.00° β=90.00° γ=90.00°
6-[(2-Methylphenyl)sulfanyl]-5-propylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C14H16N2O2S
Acta Crystallographica Section E (2014) 70, 7 o768-o769
a=10.3434(8)Å b=5.3355(3)Å c=24.4948(18)Å
α=90.00° β=91.171(3)° γ=90.00°
Diethyl 4-[2-(4-methoxyphenyl)-1<i>H</i>-pyrazol-3-yl]-2,6-dimethyl- 1,4-dihydropyridine-3,5-dicarboxylate
C23H27N3O5
Acta Crystallographica Section E (2011) 67, 6 o1417-o1418
a=8.58000(10)Å b=11.12860(10)Å c=11.49960(10)Å
α=94.4250(10)° β=99.1910(10)° γ=92.9920(10)°
3a,8a-Dihydroxy-1,3,3a,8a-tetrahydroindeno[1,2-<i>d</i>]imidazole-2,8-dione
C10H8N2O4
Acta Crystallographica Section E (2011) 67, 6 o1525
a=6.7914(2)Å b=7.3201(2)Å c=9.5006(3)Å
α=94.2580(10)° β=102.7730(10)° γ=93.7250(10)°
2-Oxo-2-phenylethyl benzoate
C15H12O3
Acta Crystallographica Section E (2011) 67, 6 o1528
a=9.0299(13)Å b=14.116(2)Å c=9.6379(14)Å
α=90.00° β=90.564(3)° γ=90.00°
2-(4-Bromophenyl)-2-oxoethyl 4-methoxybenzoate
C16H13BrO4
Acta Crystallographica Section E (2011) 67, 6 o1529
a=7.9700(5)Å b=7.9852(5)Å c=11.3185(7)Å
α=86.5360(10)° β=83.2050(10)° γ=89.6330(10)°
(<i>E</i>,<i>E</i>)-1,2-Bis(2,4,5-trimethoxybenzylidene)hydrazine
C20H24N2O6
Acta Crystallographica Section E (2011) 67, 6 o1526-o1527
a=7.50560(10)Å b=7.25230(10)Å c=17.4489(2)Å
α=90.00° β=90.6000(10)° γ=90.00°
2-Methyl-5-nitro-1<i>H</i>-benzimidazole monohydrate
C8H7N3O2,H2O
Acta Crystallographica Section E (2011) 67, 6 o1523-o1524
a=6.9051(10)Å b=7.1309(11)Å c=10.0653(15)Å
α=79.421(3)° β=73.062(3)° γ=67.517(3)°
2-[(<i>E</i>)-(2,4-Dihydroxybenzylidene)azaniumyl]-3-phenylpropanoate
C16H15NO4
Acta Crystallographica Section E (2011) 67, 6 o1331-o1332
a=9.39430(10)Å b=6.89460(10)Å c=20.7251(3)Å
α=90.00° β=92.0650(10)° γ=90.00°
(2<i>E</i>)-3-[3-(Benzyloxy)phenyl]-1-(2-hydroxyphenyl)prop-2-en-1-one
C22H18O3
Acta Crystallographica Section E (2011) 67, 6 o1313-o1314
a=6.63430(10)Å b=35.7706(5)Å c=8.15370(10)Å
α=90.00° β=121.8790(10)° γ=90.00°
(3<i>E</i>,5<i>E</i>)-3,5-Dibenzylidene-1-[3-(piperidin-1- yl)propanoyl]piperidin-4-one
C27H30N2O2
Acta Crystallographica Section E (2011) 67, 6 o1299-o1300
a=9.7757(6)Å b=10.9562(6)Å c=20.9400(15)Å
α=93.0650(10)° β=96.5940(10)° γ=90.1150(10)°
1-Benzyl-5-methoxy-2',3-dimethyl-4,6-dioxa-2-azaspiro[bicyclo[3.2.0]hept- 2-ene-7,4'-isoquinoline]-1',3'(2'<i>H</i>,4'<i>H</i>)-dione
C22H20N2O5
Acta Crystallographica Section E (2011) 67, 6 o1311-o1312
a=9.7261(2)Å b=12.4444(2)Å c=15.8413(3)Å
α=90.00° β=108.8840(10)° γ=90.00°
5-Methoxy-1,2',3-trimethyl-4,6-dioxa-2-azaspiro[bicyclo[3.2.0]hept-2-ene- 7,4'-isoquinoline]-1',3'(2'<i>H</i>,4'<i>H</i>)-dione
C16H16N2O5
Acta Crystallographica Section E (2011) 67, 6 o1340-o1341
a=7.36430(10)Å b=29.8703(6)Å c=6.78020(10)Å
α=90.00° β=105.2940(10)° γ=90.00°
Methyl 4'-isobutyl-2,2'-dimethyl-1,3-dioxo-2,3-dihydro-1<i>H</i>,4'<i>H</i>- spiro[isoquinoline-4,5'-oxazole]-4'-carboxylate
C19H22N2O5
Acta Crystallographica Section E (2011) 67, 6 o1519-o1520
a=8.67640(10)Å b=8.93660(10)Å c=12.0684(2)Å
α=93.4950(10)° β=109.8920(10)° γ=98.4260(10)°
Methyl 4'-benzyl-2,2'-dimethyl-1,3-dioxo-2,3-dihydro-1<i>H</i>,4'<i>H</i>-spiro[isoquinoline-4,5'-oxazole]-4'-carboxylate
C22H20N2O5
Acta Crystallographica Section E (2011) 67, 6 o1517-o1518
a=8.6834(7)Å b=11.1683(9)Å c=11.3085(9)Å
α=100.638(2)° β=106.347(2)° γ=109.383(2)°
(3<i>E</i>,5<i>E</i>)-1-Acryloyl-3,5-bis(2,4-dichlorobenzylidene)piperidin-4-one hemihydrate
2(C22H15Cl4NO2),H2O
Acta Crystallographica Section E (2011) 67, 6 o1301-o1302
a=27.0296(12)Å b=11.3031(5)Å c=18.9580(14)Å
α=90.00° β=133.807(2)° γ=90.00°
Hopeahainol C monohydrate
C28H16O6,H2O
Acta Crystallographica Section E (2011) 67, 6 o1392-o1393
a=21.225(4)Å b=3.8500(7)Å c=25.353(5)Å
α=90.00° β=108.933(4)° γ=90.00°
(<i>E</i>)-3-[4-(Dimethylamino)phenyl]-1-(2-methyl-4-phenylquinolin- 3-yl)prop-2-en-1-one 0.7-hydrate
C27H24N2O,0.7(H2O)
Acta Crystallographica Section E (2011) 67, 6 o1521-o1522
a=9.2653(2)Å b=10.6076(2)Å c=12.2347(2)Å
α=66.4090(10)° β=87.7580(10)° γ=80.3080(10)°
2-(4-Chlorophenyl)-2-oxoethyl 3-(trifluoromethyl)benzoate
C16H10ClF3O3
Acta Crystallographica Section E (2011) 67, 7 o1597
a=14.3036(7)Å b=12.1335(6)Å c=8.5464(4)Å
α=90.00° β=101.4440(10)° γ=90.00°
Opipramol
C23H29N3O
Acta Crystallographica Section E (2011) 67, 7 o1598
a=12.6215(2)Å b=10.5929(2)Å c=14.3629(2)Å
α=90.00° β=90.9660(10)° γ=90.00°
2-(4-Chlorophenyl)-2-oxoethyl 2-methoxybenzoate
C16H13ClO4
Acta Crystallographica Section E (2011) 67, 7 o1687
a=7.7207(6)Å b=14.4411(12)Å c=26.064(2)Å
α=90.00° β=90.00° γ=90.00°
Diethyl 4-[5-(biphenyl-4-yl)-1<i>H</i>-pyrazol-4-yl]-2,6-dimethyl- 1,4-dihydropyridine-3,5-dicarboxylate ethanol monosolvate
C28H29N3O4,C2H6O
Acta Crystallographica Section E (2011) 67, 7 o1768-o1769
a=34.884(2)Å b=10.2322(7)Å c=7.8449(6)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-1-(4-Aminophenyl)-3-(pyridin-3-yl)prop-2-en-1-one
C14H12N2O
Acta Crystallographica Section E (2011) 67, 7 o1770-o1771
a=12.0046(12)Å b=7.9329(9)Å c=22.925(3)Å
α=90.00° β=90.00° γ=90.00°
Glycozolidal
C15H13NO3
Acta Crystallographica Section E (2011) 67, 7 o1811-o1812
a=20.5756(4)Å b=8.12980(10)Å c=14.0411(3)Å
α=90.00° β=98.8710(10)° γ=90.00°
2-(4-Bromophenyl)-2-oxoethyl 2-methoxybenzoate
C16H13BrO4
Acta Crystallographica Section E (2011) 67, 7 o1724
a=7.8424(5)Å b=14.6799(9)Å c=25.7677(14)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Chlorophenyl)-2-oxoethyl 2,4-difluorobenzoate
C15H9ClF2O3
Acta Crystallographica Section E (2011) 67, 7 o1599
a=16.0179(17)Å b=7.9609(8)Å c=24.0172(18)Å
α=90.00° β=115.939(5)° γ=90.00°
4-{[5-(4-Chlorophenyl)-1-(4-fluorophenyl)-1<i>H</i>-pyrazol-3-yl]carbonyl}- <i>N</i>-ethylpiperazine-1-carboxamide
C23H23ClFN5O2
Acta Crystallographica Section E (2011) 67, 7 o1747-o1748
a=25.8566(6)Å b=10.0475(2)Å c=16.8822(4)Å
α=90.00° β=92.5250(10)° γ=90.00°
(<i>E</i>)-2-(4-Hydroxy-3-methoxybenzylidene)hydrazinecarboxamide
C9H11N3O3
Acta Crystallographica Section E (2011) 67, 7 o1786
a=13.8568(3)Å b=5.03790(10)Å c=26.8582(5)Å
α=90.00° β=90.00° γ=90.00°
3,3'-[1,2-Phenylenebis(methylene)]bis(1-heptylbenzimidazolium) dibromide monohydrate
C36H48N42,2(Br),H2O
Acta Crystallographica Section E (2011) 67, 7 o1814-o1815
a=8.84940(10)Å b=14.7170(3)Å c=16.0838(2)Å
α=115.7050(10)° β=105.3800(10)° γ=91.9460(10)°
2,2'-(Thiophen-3-ylmethanetriyl)bis(3-hydroxy-5,5-dimethylcyclohex-2-enone)
C21H26O4S
Acta Crystallographica Section E (2011) 67, 7 o1813
a=20.37700(10)Å b=20.37700(10)Å c=36.9066(7)Å
α=90.00° β=90.00° γ=90.00°
2-Hydroxy-2-(3-oxobutan-2-yl)indan-1,3-dione
C13H12O4
Acta Crystallographica Section E (2011) 67, 7 o1576
a=9.5080(5)Å b=6.7200(4)Å c=17.5195(9)Å
α=90.00° β=101.0440(10)° γ=90.00°
Methyl 2-acetamido-2-(4-hydroxy-2-methyl-1,3-dioxo- 1,2,3,4-tetrahydroisoquinolin-4-yl)-4-methylpentanoate
C19H24N2O6
Acta Crystallographica Section E (2011) 67, 7 o1710-o1711
a=17.8256(15)Å b=8.7584(6)Å c=11.9182(8)Å
α=90.00° β=100.404(5)° γ=90.00°
3-(4-Chlorophenyl)-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C16H11ClN2O
Acta Crystallographica Section E (2011) 67, 7 o1783-o1784
a=16.0429(4)Å b=4.85850(10)Å c=16.7960(4)Å
α=90.00° β=96.5810(10)° γ=90.00°
(<i>E</i>)-2-(4-Chlorobenzylidene)indan-1-one
C16H11ClO
Acta Crystallographica Section E (2011) 67, 8 o2064
a=3.8649(2)Å b=6.5233(3)Å c=12.1703(6)Å
α=91.374(4)° β=95.914(4)° γ=103.483(4)°
3-[(1-Isobutyl-1<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-4-yl)amino]benzoic acid
C21H20N4O2
Acta Crystallographica Section E (2011) 67, 8 o2150
a=9.64400(10)Å b=15.1496(2)Å c=14.5286(2)Å
α=90.00° β=123.9270(10)° γ=90.00°
3-{1-[4-(2-Methylpropyl)phenyl]ethyl}-4-phenyl-1<i>H</i>- 1,2,4-triazole-5(4<i>H</i>)-thione
C20H23N3S
Acta Crystallographica Section E (2011) 67, 8 o1943
a=6.3249(2)Å b=12.4958(5)Å c=12.9125(4)Å
α=77.6490(10)° β=78.1330(10)° γ=76.5510(10)°
(5<i>E</i>)-5-(4-Methoxybenzylidene)-2-(piperidin-1-yl)-1,3-thiazol- 4(5<i>H</i>)-one
C16H18N2O2S
Acta Crystallographica Section E (2011) 67, 8 o1915
a=8.5811(3)Å b=16.5165(6)Å c=12.4930(4)Å
α=90.00° β=121.518(2)° γ=90.00°
9-(4-Hydroxyphenyl)-3,3,6,6-tetramethyl-4,5,6,9-tetrahydro-3<i>H</i>- xanthene-1,8(2<i>H</i>,7<i>H</i>)-dione
C23H26O4
Acta Crystallographica Section E (2011) 67, 8 o1876-o1877
a=9.35250(10)Å b=10.21400(10)Å c=11.69130(10)Å
α=67.2710(10)° β=76.1190(10)° γ=69.4190(10)°
2-cyano-2-{2-[5,6-dimethyl-4-(thiophen-2-yl)-1<i>H</i>-pyrazolo[3,4- <i>b</i>]pyridin-3-yl]hydrazinylidene}acetate
C17H16N6O2S
Acta Crystallographica Section E (2011) 67, 8 o2145-o2146
a=8.0672(5)Å b=10.6460(7)Å c=20.5892(13)Å
α=90.00° β=90.3320(10)° γ=90.00°
<i>N</i>-(5-Bromopyridin-2-yl)acetamide
C7H7BrN2O
Acta Crystallographica Section E (2011) 67, 8 o2043
a=4.0014(3)Å b=8.7232(6)Å c=23.0626(18)Å
α=82.1270(10)° β=86.8970(10)° γ=85.9320(10)°
2,4-Bis[(3-allylimidazolium-1-yl)methyl]mesitylene bis(hexafluoridophosphate)
C23H30N42,2(F6P)
Acta Crystallographica Section E (2011) 67, 8 o2068
a=11.9269(4)Å b=19.1480(6)Å c=12.4233(4)Å
α=90.00° β=103.4790(10)° γ=90.00°
Bis{2-[(<i>E</i>)-(4-fluorobenzyl)iminomethyl]-6-methoxyphenolato- κ^2^<i>N</i>,<i>O</i>^1^}nickel(II)
C30H26F2N2NiO4
Acta Crystallographica Section E (2011) 67, 8 m1010-m1011
a=5.0110(2)Å b=10.9309(4)Å c=12.2435(5)Å
α=109.631(2)° β=99.083(3)° γ=91.020(3)°
Methyl (2<i>Z</i>)-2-(2-fluoro-4-methoxybenzylidene)-5-(4-methoxyphenyl)- 7-methyl-3-oxo-2,3-dihydro-5<i>H</i>-[1,3]thiazolo[3,2-<i>a</i>]pyrimidine- 6-carboxylate
C24H21FN2O5S
Acta Crystallographica Section E (2011) 67, 8 o1913-o1914
a=11.7374(2)Å b=14.3062(2)Å c=14.5552(2)Å
α=61.9390(10)° β=80.7910(10)° γ=84.8780(10)°
Bis(μ~2~-2-amino-5-nitrobenzoato)bis(2-amino-5-nitrobenzoato)octabutyldi- μ~3~-oxido-tetratin(IV)
C60H92N8O18Sn4
Acta Crystallographica Section E (2011) 67, 8 m1114-m1115
a=14.3292(2)Å b=15.3691(2)Å c=18.2096(2)Å
α=80.2890(10)° β=74.9820(10)° γ=65.6310(10)°
<i>N</i>-[(<i>E</i>)-4-Chlorobenzylidene]-2,4-dimethylaniline
C15H14ClN
Acta Crystallographica Section E (2011) 67, 8 o1932
a=7.28520(10)Å b=15.2715(2)Å c=11.53820(10)Å
α=90.00° β=96.3040(10)° γ=90.00°
2-[(<i>E</i>)-(2,4,6-Trichlorophenyl)iminomethyl]phenol
C13H8Cl3NO
Acta Crystallographica Section E (2011) 67, 8 o1934
a=12.8847(16)Å b=6.9505(9)Å c=14.4265(18)Å
α=90.00° β=96.612(2)° γ=90.00°
2-[(<i>E</i>)-(2,4-Dimethylphenyl)iminomethyl]phenol
C15H15NO
Acta Crystallographica Section E (2011) 67, 8 o1933
a=7.3161(4)Å b=12.0287(7)Å c=28.1634(15)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(2-Chlorophenyl)-2-({5-[4-(methylsulfanyl)benzyl]-4-phenyl-4<i>H</i>- 1,2,4-triazol-3-yl}sulfanyl)acetamide
C24H21ClN4OS2
Acta Crystallographica Section E (2011) 67, 8 o2063
a=14.2542(7)Å b=16.3273(9)Å c=10.1584(6)Å
α=90.00° β=96.3720(10)° γ=90.00°
3,3'-Di-<i>n</i>-propyl-1,1'-[<i>p</i>-phenylenebis(methylene)]diimidazolium dibromide
C20H28N42,2(Br)
Acta Crystallographica Section E (2011) 67, 8 o1931
a=8.9420(2)Å b=11.2443(2)Å c=11.3536(2)Å
α=90.00° β=109.7160(10)° γ=90.00°
3,5-Diamino-4<i>H</i>-1,2,4-triazol-1-ium hydroxonium bis(pyridine-2,6-dicarboxylato)cobaltate(II) pyridine-2,6-dicarboxylic acid monohydrate
C2H6N5,H3O,C14H6CoN2O82,C7H5NO4,H2O
Acta Crystallographica Section E (2011) 67, 8 m1105-m1106
a=8.0209(2)Å b=9.2028(2)Å c=18.7004(4)Å
α=98.5360(10)° β=96.7210(10)° γ=100.5150(10)°
[2-(1<i>H</i>-Benzimidazol-2-yl-κ<i>N</i>^3^)aniline-κ<i>N</i>]dichloridozinc
C13H11Cl2N3Zn
Acta Crystallographica Section E (2011) 67, 8 m1062-m1063
a=22.0252(7)Å b=10.0651(3)Å c=15.3676(6)Å
α=90.00° β=125.244(2)° γ=90.00°
2-Amino-6-methylpyridinium 2-carboxybenzoate
C6H9N2,C8H5O4
Acta Crystallographica Section E (2011) 67, 9 o2402
a=7.473(2)Å b=8.386(3)Å c=11.818(4)Å
α=97.401(6)° β=102.940(7)° γ=109.616(6)°
4'-(4-Chlorophenyl)-1'-methyldispiro[indan-2,2'-pyrrolidine-3',2''-indan]- 1,3,1''-trione
C27H20ClNO3
Acta Crystallographica Section E (2011) 67, 9 o2404
a=7.82160(10)Å b=21.2865(3)Å c=14.0641(2)Å
α=90.00° β=116.1560(10)° γ=90.00°
Ethyl 1-[3-(1<i>H</i>-imidazol-1-yl)propyl]-2-(4-chlorophenyl)-1<i>H</i>- benzo[<i>d</i>]imidazole-5-carboxylate dihydrate
C22H21ClN4O2,2(H2O)
Acta Crystallographica Section E (2011) 67, 9 o2405
a=9.06110(10)Å b=13.8393(2)Å c=18.0470(3)Å
α=90.00° β=92.3860(10)° γ=90.00°
Ethyl 5-methyl-1-(4-nitrophenyl)-1<i>H</i>-1,2,3-triazole-4-carboxylate
C12H12N4O4
Acta Crystallographica Section E (2011) 67, 9 o2416
a=13.5309(3)Å b=7.3014(2)Å c=12.6058(3)Å
α=90.00° β=99.5740(10)° γ=90.00°
3-(4-Nitrophenyl)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C8H6N4O2S
Acta Crystallographica Section E (2011) 67, 9 o2413
a=7.82210(10)Å b=8.21090(10)Å c=14.6757(3)Å
α=90.00° β=101.3020(10)° γ=90.00°
1-(<i>tert</i>-Butoxycarbonyl)piperidine-4-carboxylic acid
C11H19NO4
Acta Crystallographica Section E (2011) 67, 9 o2215
a=10.7006(3)Å b=6.5567(2)Å c=17.9297(6)Å
α=90.00° β=104.564(2)° γ=90.00°
<i>N</i>,<i>N</i>'-(Ethane-1,2-diyl)dibenzenesulfonamide
C14H16N2O4S2
Acta Crystallographica Section E (2011) 67, 9 o2214
a=5.2115(4)Å b=16.6905(13)Å c=17.8750(14)Å
α=90.00° β=93.187(2)° γ=90.00°
Naphthalen-1-aminium chloride
C10H10N,Cl
Acta Crystallographica Section E (2011) 67, 9 o2365
a=13.9691(11)Å b=5.2811(4)Å c=12.1640(10)Å
α=90.00° β=93.791(2)° γ=90.00°
(<i>E</i>)-1-(2-Hydroxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one
C18H18O5
Acta Crystallographica Section E (2011) 67, 9 o2287-o2288
a=4.2891(2)Å b=17.3341(9)Å c=20.5732(10)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-2-(4-Bromobenzylidene)indan-1-one
C16H11BrO
Acta Crystallographica Section E (2011) 67, 9 o2306-o2307
a=6.1933(7)Å b=4.7441(5)Å c=21.8572(19)Å
α=90.00° β=99.108(3)° γ=90.00°
(4-Chloro-3-nitrobenzoato)triphenyltin(IV)
C25H18ClNO4Sn
Acta Crystallographica Section E (2011) 67, 9 m1270-m1271
a=12.3926(2)Å b=8.80330(10)Å c=21.5592(3)Å
α=90.00° β=103.2170(10)° γ=90.00°
2-[5-(4-Methoxyphenyl)-3-phenyl-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]-6-methyl- 1,3-benzothiazole
C24H21N3OS
Acta Crystallographica Section E (2011) 67, 9 o2412
a=22.632(3)Å b=11.1961(12)Å c=16.1137(18)Å
α=90.00° β=90.00° γ=90.00°
2-(5,6-dihydrobenzimidazo[1,2-<i>c</i>]quinazolin-6-yl)5-methoxyphenol
C21H17N3O2
Acta Crystallographica Section E (2011) 67, 9 o2410-o2411
a=9.54080(10)Å b=15.6503(2)Å c=11.76090(10)Å
α=90.00° β=110.4080(10)° γ=90.00°
(<i>E</i>)-2-[4-(Diethylamino)styryl]-1-methylpyridinium 4-chlorobenzenesulfonate monohydrate
C18H23N2,C6H4ClO3S,H2O
Acta Crystallographica Section E (2011) 67, 9 o2488-o2489
a=7.2511(3)Å b=10.2272(4)Å c=16.7169(7)Å
α=88.441(3)° β=80.057(2)° γ=77.062(2)°
3,3'-Diallyl-1,1'-[<i>o</i>-phenylenebis(methylene)]diimidazol-3-ium bis(hexafluorophosphate)
C20H24N42,2(F6P)
Acta Crystallographica Section E (2011) 67, 9 o2529-o2530
a=7.3151(3)Å b=12.4913(4)Å c=13.8569(5)Å
α=101.8100(10)° β=94.6030(10)° γ=91.4240(10)°